News Release

<< Back
Ra Pharmaceuticals to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 7, 2017-- Ra Pharmaceuticals, Inc. (NASDAQ:RARX), a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for the treatment of complement-mediated diseases, today announced that Doug Treco, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the BMO Capital Markets Prescriptions for Success Healthcare Conference on Thursday, December 14, 2017 at 3:30 p.m. E.T. The conference is being held at the Westin New York Grand Central Hotel.

A live webcast of the presentation can be accessed by visiting the investor relations section of the Company’s website, www.rapharma.com. A replay of the presentation will also be available and archived on the site for three weeks.

About Ra Pharmaceuticals

Ra Pharmaceuticals is a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for complement-mediated diseases. The Company discovers and develops peptides and small molecules to target key components of the complement cascade. For more information, please visit: www.rapharma.com.

Source: Ra Pharmaceuticals

Ra Pharmaceuticals, Inc.
Investors:
Jennifer Robinson, 617-674-9873
jrobinson@rapharma.com
or
Media:
Argot Partners
Eliza Schleifstein, 917-763-8106
eliza@argotpartners.com